angiotensin ii has been researched along with Cardiac Output, Low in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (5.80) | 18.7374 |
1990's | 29 (42.03) | 18.2507 |
2000's | 36 (52.17) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brubaker, PH; Kitzman, DW; Moore, JB; Stewart, KP; Wesley, DJ | 1 |
Guski, H; Persson, PB; Stauss, HM; Wilfert, K | 1 |
Altruda, F; Brancaccio, M; De Acetis, M; Fratta, L; Guazzone, S; Hirsch, E; Lembo, G; Marino, G; Notte, A; Poulet, R; Silengo, L; Tarone, G; Vecchione, C | 1 |
Angelini, A; Dalla Libera, L; Danieli Betto, D; Della Barbera, M; Germinario, E; Gobbo, V; Ravara, B; Vescovo, G; Volterrani, M | 1 |
Bristow, MR; Canver, CC; Keller, RS; Lin, Q; Speth, R; Weaver, B; Zisman, LS | 1 |
Charles, CJ; Espiner, EA; Frampton, CM; Nicholls, MG; Rademaker, MT; Richards, AM | 1 |
Holycross, BJ; Radin, MJ | 1 |
Ahmed, MS; Andersson, Y; Attramadal, H; Attramadal, T; Vinge, LE; Yndestad, A; Øie, E; Øystein Andersen, G | 1 |
De Mello, WC | 1 |
Blankesteijn, WM; Bornstein, P; Cleutjens, JP; Crijns, HJ; Daemen, MJ; Debets, JJ; Duisters, R; Evelo, CT; Heymans, S; Janssen, BJ; Pinto, YM; Pokharel, S; Porter, JG; Schroen, B; Sharma, U; Smits, JF; van Leeuwen, RE | 1 |
Campbell, DJ; Esler, MD; Horowitz, JD; Zeitz, CJ | 1 |
Gao, L; Patel, KP; Wang, W; Zhu, GQ; Zucker, IH | 1 |
Opie, LH | 1 |
Edvinsson, L; Emilson, M; Malmsjö, M; Pantev, E; Wackenfors, A | 1 |
Bertsche, T; Schulz, M | 1 |
Delbridge, LM; Domenighetti, AA; Egger, M; Pedrazzini, T; Richards, SM; Wang, Q | 1 |
Batenburg, WW; Chai, W; Danser, AH; de Vries, R; Garrelds, IM; van Kats, JP | 1 |
Liu, JL; Zucker, IH | 2 |
Ma, R; Wang, W | 1 |
Ikushima, M; Ito, N; Kaibe, M; Katsuya, T; Ogihara, T; Ohishi, M; Rakugi, H; Shiota, A; Sugano, S; Takeda, S; Tatara, Y; Yamamoto, K | 1 |
Baklanova, NA; Belenkov, IuN; Mareev, VIu; Masenko, VP; Nasonova, SN; Orlova, IaA; Skvortsov, AA; Sychev, AV | 1 |
Nickenig, G; Ostergren, J; Struijker-Boudier, H | 1 |
Cornish, KG; Gao, L; Liu, D; Roy, SK; Zucker, IH | 1 |
Lim, H; Zhu, YZ | 1 |
Almeida, AP; Araújo, CA; Caliari, MV; Ferreira, AJ; Jacoby, BA; Macedo, FA; Santos, RA; Silva, GA | 1 |
Fujita, T; Goto, A; Kobayashi, N; Matsuoka, H; Onozato, ML; Tojo, A | 1 |
Assad-Kottner, C; Jahanyar, J; Koerner, MM; Loebe, M; Noon, GP; Torre-Amione, G; Youker, KA | 1 |
Kuroda, T; Shida, H | 2 |
Imazeki, T; Matsunaga, H; Nagaoka, H; Sakamoto, T; Yamada, T | 1 |
Bloom, SR; Clark, P; Cleland, JG; Crossman, D; Ghatei, MA; Good, JM; Nihoyannopoulos, P; Oakley, CM | 1 |
Carter, TL; Lamberti, JJ; Mainwaring, RD; Moore, JW; Nelson, JC | 1 |
Forster, C; Larosa, G; Naik, GO | 1 |
Freeman, GL; Herlihy, JT; Porsa, E | 1 |
Ageev, FT; Belenkov, IuN; Dzhakhangirov, TSh; Gkhani, P; Lopatin, IuM; Mareev, VIu | 1 |
Rajfer, SI; Rush, JE | 1 |
Anversa, P; Capasso, JM; Li, P; Meggs, LG; Zhang, X | 1 |
Pitts, VH; Roy, BJ; Townsley, MI | 1 |
Compagnon, P; Desché, P; Devaux, B; Elfertak, L; Henry, JP; Macé, B; Mulder, P; Richard, V; Scalbert, E; ThuilleZ, C | 1 |
Perryman, MB; Raynolds, MV | 1 |
Richards, AM | 1 |
Liu, JL; Murakami, H; Zucker, IH | 1 |
Pitt, B | 1 |
Barr, CS; Fenwick, M; MacFadyen, RJ; Struthers, AD; Sturrock, ND | 1 |
Dong, L; Ji, Y; Ren, X; Su, J; Wu, L; Zhao, Y | 1 |
Lefebvre, P | 1 |
Ivey, CL; Roy, BJ; Townsley, MI | 1 |
Komuro, I; Shiojima, I; Yamazaki, T; Yazaki, Y | 1 |
Davie, AP; McMurray, JJ | 1 |
Baker, KM; Dostal, DE | 1 |
Cartee, RE; Dai, J; Dell'italia, LJ; Dillon, AR; Hankes, GH; Ku, DD; Pohost, GM; Straeter-Knowlen, IM | 1 |
Lohmeier, TE; Mizelle, HL; Montani, JP; Reinhart, GA | 1 |
Berder, V; Juilliére, Y | 1 |
Cohen-Solal, A | 1 |
Deray, G | 1 |
Hasegawa, K; Iwai-Kanai, E; Sasayama, S | 1 |
Bie, P; Christensen, NJ; Dige-Petersen, H; Frandsen, E; Gabrielsen, A; Galatius, S; Holstein-Rathlou, NH; Kastrup, J; Norsk, P; Pump, B; Sørensen, VB; Warberg, J | 1 |
Liu, JL; Patel, KP; Pliquett, RU; Wang, W; Zucker, IH | 1 |
Hanon, S; Le Jemtel, TH; Sonnenblick, EH; Vijayaraman, P | 1 |
Guo, Z; Lai, W; Li, J; Li, S; Liu, Y; Wu, P; Xiu, JC; Xu, JP; Zhang, Y | 1 |
Cleland, JG; Frost, G; Krikler, S; Oakley, CM; Shah, D | 1 |
Bagger, JP; Danielsen, H; Eiskjaer, H; Jensen, JD; Jespersen, B; Pedersen, EB; Sørensen, SS; Thomsen, K | 1 |
Arnolda, L; Johnston, CI; McGrath, BP | 1 |
Daugherty, S; Fonken, SJ; Goldman, S; Lee, RW; Morkin, E; Raya, TE; Timmermans, PB; Wong, PC | 1 |
Bumpus, FM; Healy, B; Husain, A; Stewart, RW; Urata, H | 1 |
Bumpus, FM; Fouad-Tarazi, FM; Healy, B; Hirakata, H; Husain, A; Khosla, M; Kumagai, H; Urata, H | 1 |
Bond, M; Czerska, B; Moravec, CS; Paranandi, L; Rosenkranz, E; Schluchter, MD; Stewart, RW | 1 |
Elsner, D; Kromer, EP; Riegger, GA | 1 |
16 review(s) available for angiotensin ii and Cardiac Output, Low
Article | Year |
---|---|
Cytokines in heart failure: potential interactions with angiotensin II and leptin.
Topics: Angiotensin II; Animals; Cardiac Output, Low; Cytokines; Humans; Leptin; Models, Biological; Myocardium; Signal Transduction | 2002 |
Heart failure: how important is cellular sequestration? The role of the renin-angiotensin-aldosterone system.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Cardiac Output, Low; Cell Communication; Fibroblasts; Fibrosis; Humans; Renin-Angiotensin System; Signal Transduction; Sympathetic Nervous System | 2004 |
[Angiotensin receptor antagonists. A clinical-pharmacologic overview].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Cardiac Output, Low; Diabetic Nephropathies; Humans; Kidney Diseases; Migraine Disorders; Myocardial Infarction | 2005 |
Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure.
Topics: Angiotensin II; Animals; Baroreflex; Cardiac Output, Low; Disease Models, Animal; Excitatory Postsynaptic Potentials; Exercise; Heart Failure; Hemodynamics; Humans; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rabbits; Risk Factors; Sensitivity and Specificity; Sympathetic Nervous System | 2000 |
Cardiac sympathetic afferent reflexes in heart failure.
Topics: Afferent Pathways; Angiotensin II; Animals; Baroreflex; Bradykinin; Capsaicin; Cardiac Output, Low; Disease Models, Animal; Dogs; Heart; Heart Failure; Nitric Oxide; Reference Values; Sensitivity and Specificity; Sympathetic Nervous System | 2000 |
Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Cardiac Output, Low; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Humans; Hypertension; Kidney Diseases; Renin-Angiotensin System | 2006 |
Role of transforming growth factor-beta in the progression of heart failure.
Topics: Angiotensin II; Animals; Cardiac Output, Low; Chronic Disease; Disease Progression; Heart Diseases; Humans; Myocardium; Signal Transduction; Transforming Growth Factor beta; Ventricular Remodeling | 2006 |
Theoretical basis for the use of angiotensin II antagonists in the treatment of heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Cardiac Output, Low; Humans; Imidazoles; Losartan; Tetrazoles | 1993 |
The role of genetic variants in angiotensin I converting enzyme, angiotensinogen and the angiotensin II type-1 receptor in the pathophysiology of heart muscle disease.
Topics: Angiotensin II; Angiotensinogen; Bradykinin; Cardiac Output, Low; Cardiomegaly; Genetic Variation; Heart Diseases; Humans; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Renin-Angiotensin System | 1995 |
The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiac Output, Low; Central Nervous System; Dogs; Humans; Hypertension; Male; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Proteins; Rats; Renin; Renin-Angiotensin System; Sheep | 1996 |
ACE inhibitors in heart failure: prospects and limitations.
Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Cardiac Output, Low; Cough; Creatinine; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Ventricular Function, Left | 1997 |
[The advent of a new class of antihypertensive agents: angiotensin II receptor antagonists].
Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; Cardiac Output, Low; Controlled Clinical Trials as Topic; Diuretics; Humans; Hypertension; Incidence; Losartan; Patient Compliance; Placebos; Sodium Chloride Symporter Inhibitors | 1997 |
The molecular mechanism of cardiac hypertrophy and failure.
Topics: Angiotensin II; Animals; Cardiac Output, Low; Cardiomegaly; Endothelin-1; Hypertension; Myocardium; Renin-Angiotensin System; Signal Transduction; Sodium-Hydrogen Exchangers; Stress, Mechanical | 1999 |
The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Cardiac Output, Low; Heart; Humans; Myocardium; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System | 1999 |
The regulation of sympathetic outflow in heart failure. The roles of angiotensin II, nitric oxide, and exercise training.
Topics: Angiotensin II; Animals; Cardiac Output, Low; Chronic Disease; Endothelin-1; Nitric Oxide; Physical Conditioning, Animal; Sympathetic Nervous System | 2001 |
Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Chronic Disease; Dose-Response Relationship, Drug; Humans; Randomized Controlled Trials as Topic | 2000 |
9 trial(s) available for angiotensin ii and Cardiac Output, Low
Article | Year |
---|---|
Endurance exercise training in older patients with heart failure: results from a randomized, controlled, single-blind trial.
Topics: Aged; Aldosterone; Anaerobic Threshold; Angiotensin II; Cardiac Output, Low; Cardiac Volume; Echocardiography; Exercise; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Oxygen; Physical Endurance; Prospective Studies; Quality of Life; Single-Blind Method; Stroke Volume; Treatment Failure; Ventricular Dysfunction, Left; Ventricular Function, Left | 2009 |
Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Bosentan; Cardiac Output; Cardiac Output, Low; Cardiac Pacing, Artificial; Cyclic GMP; Endothelin Receptor Antagonists; Endothelin-1; Female; Infusions, Parenteral; Losartan; Natriuretic Peptide, Brain; Renin; Sheep; Sulfonamides | 2004 |
[Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADK
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiac Output, Low; Chronic Disease; Drug Therapy, Combination; Exercise Tolerance; Female; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Quinapril; Tetrahydroisoquinolines; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Remodeling | 2006 |
Elevated plasma endothelin concentrations in heart failure; an effect of angiotensin II?
Topics: Adult; Aged; Angiotensin II; Cardiac Output, Low; Coronary Disease; Endothelins; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies | 1994 |
[Comparative study on use of angiotensin-converting enzyme inhibitors and cardiac glycosides in the treatment of cardiac insufficiency].
Topics: Adult; Aged; Angiotensin II; Baroreflex; Captopril; Cardiac Output, Low; Chronic Disease; Digoxin; Double-Blind Method; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Norepinephrine; Sclerosis; Stroke Volume; Time Factors | 1993 |
Further evidence that chronic perindopril treatment maintains neurohormonal suppression but does not lower blood pressure in chronic cardiac failure.
Topics: Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiac Output, Low; Chronic Disease; Depression, Chemical; Female; Humans; Indoles; Kidney Function Tests; Male; Middle Aged; Perindopril | 1997 |
Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor.
Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Cardiac Output, Low; Dose-Response Relationship, Drug; Drug Interactions; Female; Heart Rate; Humans; Male; Peptide Fragments | 1999 |
Neuroendocrine and renal effects of intravascular volume expansion in compensated heart failure.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Cardiac Output, Low; Enzyme Inhibitors; Fluid Shifts; Glomerular Filtration Rate; Heart Rate; Humans; Immersion; Kidney; Male; Middle Aged; Natriuresis; Sodium; Urine; Vasopressins; Water-Electrolyte Balance | 2001 |
Angiotensin-converting enzyme inhibitors, left ventricular dysfunction, and early heart failure.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output, Low; Dipeptides; Double-Blind Method; Exercise Test; Glomerular Filtration Rate; Humans; Lisinopril; Male; Middle Aged; Oxygen Consumption; Placebos; Renal Circulation; Stroke Volume; Ventricular Function, Left | 1992 |
44 other study(ies) available for angiotensin ii and Cardiac Output, Low
Article | Year |
---|---|
Cardiovascular responses to angiotensin II in atherosclerosis.
Topics: Angiotensin II; Animals; Arteriosclerosis; Blood Pressure; Cardiac Output, Low; Diet, Atherogenic; Female; Hypertension; Lipids; Male; Rabbits; Vasoconstrictor Agents | 2002 |
Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload.
Topics: Angiotensin II; Animals; Aortic Coarctation; Biomechanical Phenomena; Cardiac Output, Low; Cardiomegaly; Carrier Proteins; Cytoskeletal Proteins; Echocardiography; Female; Gene Silencing; Heart Ventricles; Hemodynamics; Integrin beta1; Male; Mice; Mice, Knockout; Muscle Proteins; Muscle, Skeletal; Myocardium; Phenylephrine; Signal Transduction; Stress, Mechanical; Vasoconstrictor Agents; Ventricular Function | 2003 |
Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure.
Topics: Angiotensin II; Animals; Apoptosis; Body Weight; Cardiac Output, Low; Caspases; Cytochromes c; Human Growth Hormone; In Situ Nick-End Labeling; Insulin-Like Growth Factor I; Isometric Contraction; Male; Monocrotaline; Muscle, Skeletal; Muscular Atrophy; Myosin Heavy Chains; Physical Endurance; Rats; Rats, Sprague-Dawley; Sphingosine; Tumor Necrosis Factor-alpha | 2004 |
Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Carboxypeptidases; Cardiac Output, Low; Female; Heart Ventricles; Humans; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Up-Regulation | 2003 |
Connective tissue growth factor--a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats.
Topics: Administration, Oral; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Cardiac Output, Low; Cells, Cultured; Connective Tissue Growth Factor; Fibroblasts; Gene Expression; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Losartan; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Vasoconstrictor Agents | 2004 |
Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Cardiac Output, Low; Cardiomyopathies; Collagenases; Disease Progression; Enzyme Precursors; Extracellular Matrix; Gelatinases; Gene Expression; Gene Expression Profiling; Genetic Predisposition to Disease; Heart Rupture; Humans; Hypertension; Hypertrophy, Left Ventricular; Matrix Metalloproteinase 9; Metalloendopeptidases; Mice; Mice, Knockout; Myocardium; Rats; Rats, Sprague-Dawley; Renin; Stroke Volume; Thrombospondins; Up-Regulation | 2004 |
Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Carboxypeptidases; Cardiac Output, Low; Case-Control Studies; Coronary Circulation; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A | 2004 |
ANG II in the paraventricular nucleus potentiates the cardiac sympathetic afferent reflex in rats with heart failure.
Topics: Angiotensin II; Animals; Arteries; Cardiac Output, Low; Chronic Disease; Coronary Vessels; Dose-Response Relationship, Drug; Electric Stimulation; Heart; Hemodynamics; Kidney; Ligation; Losartan; Male; Microinjections; Neurons, Afferent; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Reflex; Sympathetic Nervous System; Vasoconstrictor Agents | 2004 |
Cellular basis for therapeutic choices in heart failure.
Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Clinical Trials as Topic; Drug Therapy, Combination; Fibrosis; Humans; Mineralocorticoid Receptor Antagonists; Myocardium; Receptors, Adrenergic, beta; Signal Transduction; Ventricular Remodeling | 2004 |
Angiotensin II receptor mRNA expression and vasoconstriction in human coronary arteries: effects of heart failure and age.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Angiotensin II; Cardiac Output, Low; Case-Control Studies; Coronary Vessels; Female; Humans; In Vitro Techniques; Male; Middle Aged; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasoconstriction | 2004 |
Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure.
Topics: Aging; Angiotensin II; Angiotensinogen; Animals; Calcium; Calcium-Transporting ATPases; Cardiac Output, Low; Cardiomegaly; Cardiomyopathy, Dilated; Male; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Phenotype; Promoter Regions, Genetic; Rats; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Ventricular Remodeling | 2005 |
Nongenomic effects of aldosterone in the human heart: interaction with angiotensin II.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Animals; Cardiac Output, Low; Coronary Vessels; Dose-Response Relationship, Drug; Drug Synergism; Estradiol; Extracellular Signal-Regulated MAP Kinases; Female; Heart; Humans; Hydrocortisone; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Myocardium; Protein Kinase C; Renal Artery; Swine; Vasoconstriction; Vasoconstrictor Agents | 2005 |
Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta; Carboxypeptidases; Cardiac Output, Low; Cardiomegaly; Cells, Cultured; Constriction, Pathologic; Enzyme Activation; Gene Deletion; Gene Expression; Heart; Hypertension; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardium; Myocytes, Cardiac; Osmolar Concentration; Peptidyl-Dipeptidase A; RNA, Messenger | 2006 |
Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase.
Topics: Angiotensin II; Animals; Body Weight; Cardiac Output, Low; Cell Line; Echocardiography; Heart; Injections, Intraventricular; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Neurons; Organ Size; Proto-Oncogene Proteins c-jun; Rabbits; Receptor, Angiotensin, Type 1; RNA, Messenger; Transcription Factor AP-1; Up-Regulation | 2006 |
The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction.
Topics: Angiotensin II; Animals; Cardiac Output, Low; Coronary Vessels; Disease Models, Animal; Enzyme Inhibitors; Heart Rate; Heart Ventricles; Imidazoles; Ligation; Male; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Time Factors; Vasoconstriction; Vasodilator Agents; Ventricular Function, Left | 2007 |
Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Drug Synergism; Eplerenone; Hypertension; Indoles; Kidney; Male; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Oxidative Stress; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Sodium-Potassium-Exchanging ATPase; Spironolactone; Superoxide Dismutase; Transforming Growth Factor beta | 2007 |
Mast cell-derived cathepsin g: a possible role in the adverse remodeling of the failing human heart.
Topics: Adult; Aged; Angiotensin II; Cardiac Output, Low; Case-Control Studies; Cathepsin G; Cathepsins; Chymases; Disease Progression; Female; Heart-Assist Devices; Humans; Male; Mast Cells; Middle Aged; Myocardium; Necrosis; Serine Endopeptidases; Tryptases; Ventricular Remodeling | 2007 |
Angiotensin II-induced myocardial damage with a special reference to low cardiac output syndrome.
Topics: Angiotensin II; Animals; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiomyopathies; Dogs; Kidney; Myocardium; Necrosis; Rabbits | 1983 |
[Effects of angiotension on the heart and kidney--with special reference to their relationship to an abnormal rise in the angiotensin II level in postoperative low cardiac output syndrome].
Topics: Angiotensin II; Animals; Cardiac Output, Low; Cardiac Surgical Procedures; Kidney; Myocardium; Postoperative Complications; Rabbits; Rats; Renin-Angiotensin System | 1982 |
[Role of the renin-angiotensin-aldosterone system in open heart surgery (author's transl)].
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Renin-Angiotensin System | 1981 |
Renin, angiotensin II, and the development of effusions following bidirectional Glenn and Fontan procedures.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Cardiac Output, Low; Cardiac Surgical Procedures; Female; Humans; Hydrocortisone; Male; Pleural Effusion; Postoperative Complications; Renin; Vasopressins | 1995 |
Myocardial beta-adrenoceptors in pacing-induced heart failure: regulation by enalapril?
Topics: Angiotensin II; Animals; Cardiac Output, Low; Cardiac Pacing, Artificial; Dogs; Enalapril; Heart Ventricles; Iodine Radioisotopes; Iodocyanopindolol; Kinetics; Male; Membranes; Myocardium; Norepinephrine; Pindolol; Radioligand Assay; Receptors, Adrenergic, beta; Renin | 1994 |
Tachycardia heart failure alters rabbit aortic smooth muscle responsiveness to angiotensin II.
Topics: Angiotensin II; Animals; Aorta; Calcium; Cardiac Output, Low; Isoproterenol; Male; Muscle, Smooth; Phenylephrine; Potassium; Rabbits; Tachycardia | 1994 |
Alterations in ANG II responsiveness in left and right myocardium after infarction-induced heart failure in rats.
Topics: Angiotensin II; Animals; Cardiac Output, Low; Hemodynamics; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Infarction; Papillary Muscles; Rats; Rats, Sprague-Dawley | 1993 |
Pulmonary vascular response to angiotensin II in canine pacing-induced heart failure.
Topics: Angiotensin II; Animals; Capillary Permeability; Cardiac Output, Low; Cardiac Pacing, Artificial; Dogs; Dose-Response Relationship, Drug; In Vitro Techniques; Pulmonary Circulation; Reference Values; Vascular Resistance; Venous Pressure | 1996 |
Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Endothelium, Vascular; Femoral Artery; Hemodynamics; In Vitro Techniques; Indoles; Male; Myocardial Infarction; Nitroprusside; Perindopril; Rats; Rats, Wistar; Vasodilator Agents | 1996 |
Angiotensin II blockade [corrected] enhances baroreflex control of sympathetic outflow in heart failure.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Cardiac Output, Low; Hemodynamics; Imidazoles; Male; Rabbits; Sympathetic Nervous System; Tetrazoles | 1997 |
Role of intracardiac angiotensin II in cardiac dysfunction of rat during septic shock.
Topics: Angiotensin II; Animals; Cardiac Output, Low; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Shock, Septic | 1996 |
Ablation of lung endothelial injury after pacing-induced heart failure is related to alterations in Ca2+ signaling.
Topics: Alkaloids; Angiotensin II; Animals; Benzophenanthridines; Calcimycin; Calcium; Capillary Permeability; Cardiac Output, Low; Cardiac Pacing, Artificial; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Ionophores; Lung; Phenanthridines; Protein Kinase C; Signal Transduction; Staurosporine; Thapsigargin; Vascular Resistance | 1998 |
Regulation of sympathetic nerve activity in heart failure: a role for nitric oxide and angiotensin II.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output, Low; Cardiac Pacing, Artificial; Chronic Disease; Hemodynamics; Kidney; Losartan; Male; Myocardium; Nitric Oxide; Nitroprusside; Organ Size; Rabbits; Reference Values; Sympathetic Nervous System | 1999 |
ACE inhibitors in HF restore canine pulmonary endothelial function and ANG II vasoconstriction.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cardiac Output, Low; Dogs; Endothelium, Vascular; Hemodynamics; In Vitro Techniques; Pulmonary Artery; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1999 |
Influence of angiotensin on the early progression of heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Proteins; Captopril; Cardiac Output, Low; Cardiac Pacing, Artificial; Disease Progression; Dogs; Electrolytes; Hematocrit; Hemodynamics; Male; Neurotransmitter Agents; Renal Circulation; Sodium Chloride; Water-Electrolyte Balance | 2000 |
[Chronic cardiac insufficiency. Treatment with angiotensin I converting enzyme inhibitors and angiotensin II receptor antagonists].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Heart Failure; Humans | 2000 |
[Angiotensin II antagonists: a promising pathway].
Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Output, Low; Chymases; Humans; Losartan; Renin-Angiotensin System; Serine Endopeptidases; Vasodilator Agents | 2000 |
[Treatment of cardiac insufficiency and the kidney: conflict of interest?].
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Cardiac Output, Low; Creatinine; Diabetes Complications; Diuretics; Humans; Hyperkalemia; Kidney; Risk Factors; Sodium Chloride Symporter Inhibitors | 2000 |
Neurohormonal regulation of myocardial cell apoptosis during the development of heart failure.
Topics: Angiotensin II; Animals; Apoptosis; Cardiac Output, Low; Cytokines; Endothelin-1; Heart; Myocardium; Neurotransmitter Agents; Receptors, Adrenergic | 2001 |
Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Cardiomegaly; Cardiovascular System; Chronic Disease; Enalapril; Losartan; Male; Mesenteric Arteries; Myocardial Infarction; Rats; Rats, Wistar | 2002 |
Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output, Low; Circadian Rhythm; Cyclic GMP; Dinoprostone; Female; Glomerular Filtration Rate; Heart Rate; Humans; Male; Middle Aged; Myocardium; Potassium; Renal Circulation; Renin; Renin-Angiotensin System; Sodium; Urinary Retention | 1991 |
Systemic and regional effects of vasopressin and angiotensin in acute left ventricular failure.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Blood Pressure; Cardiac Output, Low; Electroshock; Female; Heart Ventricles; Hemodynamics; Hormones; Male; Rabbits; Receptors, Vasopressin; Regional Blood Flow; Vasopressins | 1991 |
Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model of heart failure.
Topics: Administration, Oral; Angiotensin II; Animals; Body Weight; Captopril; Cardiac Output, Low; Compliance; Disease Models, Animal; Dose-Response Relationship, Drug; Heart; Hemodynamics; Imidazoles; Losartan; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Tetrazoles; Ventricular Function, Left | 1991 |
Angiotensin II-forming pathways in normal and failing human hearts.
Topics: Adolescent; Adult; Angiotensin I; Angiotensin II; Captopril; Cardiac Output, Low; Female; Glycine max; Heart; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Peptidyl-Dipeptidase A; Reference Values; Trypsin Inhibitors | 1990 |
Angiotensins and the failing heart. Enhanced positive inotropic response to angiotensin I in cardiomyopathic hamster heart in the presence of captopril.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensins; Animals; Captopril; Cardiac Output, Low; Cardiomyopathies; Cricetinae; Drug Synergism; Heart; Male; Mesocricetus; Myocardial Contraction; Myocardium; Receptors, Angiotensin | 1990 |
Inotropic effects of angiotensin II on human cardiac muscle in vitro.
Topics: Angiotensin II; Animals; Cardiac Output, Low; Cricetinae; Dose-Response Relationship, Drug; Heart; Humans; In Vitro Techniques; Mesocricetus; Myocardial Contraction; Papillary Muscles; Reference Values | 1990 |
Circulatory and renal control by prostaglandins and renin in low cardiac output in dogs.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Cardiac Output, Low; Dogs; Female; Indomethacin; Kidney; Norepinephrine; Prostaglandins; Renal Circulation; Renin-Angiotensin System | 1989 |